Division of Drug Delivery Technology Leiden/Amsterdam Center for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
Pharm Res. 2011 Jan;28(1):145-58. doi: 10.1007/s11095-010-0093-y. Epub 2010 Mar 17.
To determine the immunogenicity of diphtheria toxoid (DT) formulated in two types of vesicles following transcutaneous immunization (TCI) of mice onto microneedle array-treated skin.
DT-containing cationic liposomes or anionic surfactant-based vesicles were prepared by extrusion and sonication. The physicochemical properties were characterized in terms of size, ζ-potential, vesicle elasticity and antigen association. TCI was performed by applying formulations onto intact or microneedle array-pretreated mice skin, using cholera toxin as an adjuvant. Subcutaneous and intradermal immunizations were as control. Immune responses were evaluated by IgG and neutralizing antibody titers, and the immune-stimulatory properties were assessed using cultured dendritic cells.
Stable DT-containing cationic liposomes (∼150 nm) and anionic vesicles (∼100 nm) were obtained. Incorporation of Span 80 increased liposome elasticity. About 90% and 77% DT was associated with liposomes and vesicles, respectively. TCI of all formulations resulted in substantial antibody titers only if microneedle pretreatment was applied. Co-administration of cholera toxin further augmented the immune responses of TCI. However, vesicle formulations didn't enhance the immunogenicity on either intact or microneedle-treated skin and showed low stimulatory activity on dendritic cells.
Microneedle pretreatment and cholera toxin, but not antigen association to vesicles, enhances the immunogenicity of topically applied DT.
确定经皮免疫(TCI)小鼠微针阵列处理皮肤后,两种类型囊泡中白喉类毒素(DT)的免疫原性。
通过挤出和超声处理制备含 DT 的阳离子脂质体或阴离子表面活性剂囊泡。从粒径、Zeta 电位、囊泡弹性和抗原结合等方面对其理化性质进行了表征。将制剂应用于完整或微针阵列预处理的小鼠皮肤进行 TCI,并使用霍乱毒素作为佐剂。皮下和皮内免疫作为对照。通过 IgG 和中和抗体滴度评估免疫反应,并通过培养树突状细胞评估免疫刺激特性。
获得了稳定的含 DT 的阳离子脂质体(150nm)和阴离子囊泡(100nm)。加入 Span 80 可增加脂质体的弹性。大约 90%和 77%的 DT 分别与脂质体和囊泡结合。只有在应用微针预处理的情况下,所有制剂的 TCI 才会导致抗体滴度显著增加。霍乱毒素的共同给药进一步增强了 TCI 的免疫反应。然而,囊泡制剂并未增强完整或微针处理皮肤的免疫原性,并且对树突状细胞的刺激活性较低。
微针预处理和霍乱毒素,但不是抗原与囊泡的结合,增强了局部应用 DT 的免疫原性。